GCM
Glenview Capital Management Portfolio holdings
AUM
$3.52B
This Quarter Return
+17.52%
1 Year Return
+13.71%
3 Year Return
+64.03%
5 Year Return
+172.03%
10 Year Return
+274.64%
AUM
$11.2B
AUM Growth
+$11.2B
(+9.2%)
Cap. Flow
-$419M
Cap. Flow
% of AUM
-3.74%
Top 10 Holdings %
Top 10 Hldgs %
52.23%
Holding
57
New
9
Increased
21
Reduced
11
Closed
12
Top Buys
| 1 |
Takeda Pharmaceutical
TAK
|
$532M |
| 2 |
Humana
HUM
|
$300M |
| 3 |
LyondellBasell Industries
LYB
|
$279M |
| 4 |
Cigna
CI
|
$267M |
| 5 |
NXP Semiconductors
NXPI
|
$189M |
Top Sells
| 1 |
SHPG
Shire pic
SHPG
|
$794M |
| 2 |
CVS Health
CVS
|
$556M |
| 3 |
DuPont de Nemours
DD
|
$461M |
| 4 |
FDC
First Data Corporation
FDC
|
$295M |
| 5 |
IQVIA
IQV
|
$209M |
Sector Composition
| 1 | Healthcare | 52.71% |
| 2 | Technology | 13.52% |
| 3 | Materials | 12.73% |
| 4 | Communication Services | 9.13% |
| 5 | Industrials | 6.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
DXC Technology
DXC
$2.59B
| $707M | 6.31% | 10,994,368 +1,780,732 | +19% | +$115M |
|
2
FMC
FMC
$4.88B
| $704M | 6.28% | 9,167,262 +254,408 | +3% | +$19.5M |
|
|
3
Cigna
CI
$80.3B
| $704M | 6.28% | 4,376,891 +1,658,305 | +61% | +$267M |
|
4
McKesson
MCK
$85.4B
| $576M | 5.14% | 4,918,907 +398,021 | +9% | +$46.6M |
|
|
5
IQVIA
IQV
$32.4B
| $563M | 5.02% | 3,910,507 -1,452,425 | -27% | -$209M |
|
6
HCA Healthcare
HCA
$94.5B
| $553M | 4.94% | 4,243,504 -655,065 | -13% | -$85.4M |
|
|
7
Takeda Pharmaceutical
TAK
$47.3B
| $532M | 4.75% | +26,112,660 | New | +$532M |
|
8
Hologic
HOLX
$14.9B
| $521M | 4.65% | 10,758,550 +844,507 | +9% | +$40.9M |
|
9
Tenet Healthcare
THC
$16.3B
| $516M | 4.61% | 17,900,928 +5,614 | +0% | +$162K |
|
10
Alphabet (Google) Class A
GOOGL
$2.57T
| $478M | 4.26% | 405,988 -40,063 | -9% | -$47.1M |
|
|
FDC
11
DELISTED
First Data Corporation
FDC
| $382M | 3.41% | 14,553,631 -11,223,562 | -44% | -$295M |
|
|
12
LyondellBasell Industries
LYB
$18.1B
| $361M | 3.22% | 4,291,569 +3,312,724 | +338% | +$279M |
|
|
13
Humana
HUM
$36.5B
| $349M | 3.11% | 1,312,039 +1,126,844 | +608% | +$300M |
|
14
Elevance Health
ELV
$71.8B
| $292M | 2.61% | 1,018,237 +145,804 | +17% | +$41.8M |
|
|
15
NXP Semiconductors
NXPI
$59.2B
| $286M | 2.55% | 3,238,670 +2,141,625 | +195% | +$189M |
|
16
Universal Health Services
UHS
$11.6B
| $275M | 2.46% | 2,058,124 +95,577 | +5% | +$12.8M |
|
17
Thermo Fisher Scientific
TMO
$186B
| $268M | 2.4% | 980,589 -196,252 | -17% | -$53.7M |
|
18
Bausch Health
BHC
$2.74B
| $230M | 2.05% | 9,315,244 +2,724,936 | +41% | +$67.3M |
|
19
Microsoft
MSFT
$3.77T
| $224M | 2% | 1,902,131 +649,380 | +52% | +$76.6M |
|
20
Williams Companies
WMB
$70.7B
| $215M | 1.92% | 7,488,701 -1,324,432 | -15% | -$38M |
|
21
Flex
FLEX
$20.1B
| $205M | 1.83% | 20,543,849 +4,876,265 | +31% | +$48.8M |
|
|
PARA
22
DELISTED
Paramount Global Class B
PARA
| $196M | 1.75% | 4,129,237 +43,486 | +1% | +$2.07M |
|
23
Cencora
COR
$56.5B
| $173M | 1.55% | 2,180,396 +2,004,048 | +1,136% | +$159M |
|
|
MTOR
24
DELISTED
MERITOR, Inc.
MTOR
| $157M | 1.4% | 7,699,201 -600,000 | -7% | -$12.2M |
|
25
nVent Electric
NVT
$14.5B
| $151M | 1.34% | 5,579,650 -1,077,447 | -16% | -$29.1M |
|